The risk of falsely declaring noninferiority of novel latent tuberculosis treatment in large trials

Ibrahim Abubakar, Frank G. J. Cobelens, Molebogeng X. Rangaka

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	511-513
Number of pages	3
Journal	American journal of respiratory and critical care medicine
Volume	201
Issue number	5
DOIs	https://doi.org/10.1164/rccm.201911-2258ED
Publication status	Published - 1 Mar 2020

Access to Document

@article{94e8539254574e259bbbaf43a53cc3f9,

title = "The risk of falsely declaring noninferiority of novel latent tuberculosis treatment in large trials",

author = "Ibrahim Abubakar and Cobelens, {Frank G. J.} and Rangaka, {Molebogeng X.}",

year = "2020",

month = mar,

day = "1",

doi = "https://doi.org/10.1164/rccm.201911-2258ED",

language = "English",

volume = "201",

pages = "511--513",

journal = "American journal of respiratory and critical care medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "5",

}

TY - JOUR

T1 - The risk of falsely declaring noninferiority of novel latent tuberculosis treatment in large trials

AU - Abubakar, Ibrahim

AU - Cobelens, Frank G. J.

AU - Rangaka, Molebogeng X.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85080096549&partnerID=8YFLogxK

U2 - https://doi.org/10.1164/rccm.201911-2258ED

DO - https://doi.org/10.1164/rccm.201911-2258ED

M3 - Editorial

C2 - 31816247

SN - 1073-449X

VL - 201

SP - 511

EP - 513

JO - American journal of respiratory and critical care medicine

JF - American journal of respiratory and critical care medicine

IS - 5

ER -